Old Web
English
Sign In
Acemap
>
authorDetail
>
Thamer Sliwa
Thamer Sliwa
Medicine
Immunology
Intensive care medicine
Hematology
Cohort study
3
Papers
121
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pre‐fibrotic/early primary myelofibrosis vs. WHO‐defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease
2017
American Journal of Hematology
Georg Jeryczynski
Juergen Thiele
Bettina Gisslinger
Albert Wölfler
Martin Schalling
Andreas Gleiß
Sonja Burgstaller
Veronika Buxhofer-Ausch
Thamer Sliwa
Ernst Schlögl
Klaus Geissler
Maria-Theresa Krauth
Alexander Nader
Michael Vesely
Ingrid Simonitsch-Klupp
Leonhard Müllauer
Christine Beham-Schmid
Heinz Gisslinger
Show All
Source
Cite
Save
Citations (26)
Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations
2017
Supportive Care in Cancer
Matti Aapro
Ralph V. Boccia
Robert C. F. Leonard
Carlos Camps
Mario Campone
Sylvain Choquet
Marco Danova
John A. Glaspy
Iwona Hus
Hartmut Link
Thamer Sliwa
Hans Tesch
Vicente Valero
Show All
Source
Cite
Save
Citations (39)
Azacitidine in patients with WHO-defined AML - results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group.
2013
Journal of Hematology & Oncology
Lisa Pleyer
Reinhard Stauder
Sonja Burgstaller
Martin Schreder
Christoph Tinchon
Michael Pfeilstöcker
Susanne Steinkirchner
Thomas Melchardt
Martina Mitrovic
Michael Girschikofsky
Alois Lang
Peter Krippl
Thamer Sliwa
Alexander Egle
Werner Linkesch
Daniela Voskova
Hubert Angermann
Richard Greil
Show All
Source
Cite
Save
Citations (56)
1